Eli Lilly Estimates $2.8B Q2 2026 Acquired IPR&D Charges, Impacting GAAP And Non-GAAP EPS By ~$3.02 Per Share

Loading news article.

Eli Lilly Estimates $2.8B Q2 2026 Acquired IPR&D Charges, Impacting GAAP And Non-GAAP EPS By ~$3.02 Per Share | WAPE

Article summary